IFNA1 and systemic lupus erythematosus: The microRNA miR-146a is a negativeregulator of the IFN pathway; underexpression of miR-146a contributes to alterationsin the type I IFN pathway in lupus patients by targeting key signaling proteins.They suggested that their findings provide potential novel strategies fortherapeutic intervention37.